表纸
市场调查报告书

重氢化制剂治疗的市场策略

Deuterated Drugs Formulations Therapeutics Markets Strategies

出版商 Greystone Research Associates 商品编码 539022
出版日期 内容资讯 英文
商品交期: 最快1-2个工作天内
价格
Back to Top
重氢化制剂治疗的市场策略 Deuterated Drugs Formulations Therapeutics Markets Strategies
出版日期: 2017年08月07日内容资讯: 英文
简介

本报告提供重氢化制剂治疗的市场相关调查,受现在FDA的认证的,以及处于后期开发阶段的重氢化制剂,特征,上市的过程,及治疗特征,促进重氢化制剂开发的主要原因,重氢化制剂开发者的产品策略,目前市场规模及主要企业等相关分析。

摘要整理

重氢化制剂治疗

  • 制剂设计技术
  • 药物特征
  • 给药间隔的扩张
  • 治疗药的未满足需求支援

主要的短期治疗目标

  • 神经传达物质的调整
  • 薄膜传导
  • 激酶抑制剂
  • 抗发炎药
  • 粒腺体功能控制
  • 抗肿瘤药物

重氢化制剂:短期性的治疗市场分析

  • 中国
  • 自体免疫疾病
  • 遗传性疾病
  • 神经性疾病
  • 癌症
  • 眼科疾病

市场要素

  • 法规、认证
  • 临床实验 & end point
  • IP/专利要素
  • 防卫性的专利策略
  • 医疗经济学

企业简介

目录
Product Code: DTR354K

Deuterated Drugs: Products, Pipelines, Strategies, Therapeutics and Markets is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug formulation developers, product designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for drugs that incorporate deuterium into the chemical structure of APIs to modify drug properties in vivo. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Deuterated Drugs - What You Will Learn

  • What deuterated drugs are currently FDA-approved or in late-stage development, what are their distinguishing properties, how are they marketed, and what are the therapeutic specifics?
  • What are the major factors driving the development of deuterated drugs?
  • What are the product strategies of deuterated drug developers?
  • What is the size of the deuterated drug market today, who are the active sector participants, and what will the market look like in 2024?
  • How important are formulator-developer-manufacturer relationships and what are the key alliances in the industry?
  • What are the significant economic, technology, and regulatory factors affecting the market for deuterated drugs?

Table of Contents

Executive Summary

  • Drug Therapy Market Dynamics
  • Market Segments and Indications
  • Competing Technologies
  • Market Drivers
  • Drug Re-positioning/Re-purposing
  • Extending Patent Life
  • Dosing Frequency & Patient Adherence
  • Competitive Landscape
  • Formulators/Developers
  • Marketers
  • Alliances
  • Acquisitions

Deuterated Drug Therapeutics

  • Formulation Technology
  • Drug Property Kinetics
  • Extending Dosing Intervals
  • Addressing Unmet Therapeutic Needs

Selected Near-term Therapeutic Targets

  • Neurotransmitter Regulation
  • Transmembrane Conductance
  • Kinase Inhibitors
  • Anti-inflammatory
  • Mitochondrial Function Modulation
  • Antineoplastic

Deuterated Drugs - Near-term Therapeutic Market Analysis

  • Addiction
  • Autoimmune Diseases
  • Hereditary
  • Neurology
  • Oncology
  • Ophthalmology

Market Factors

  • Regulations and Approvals
  • Clinical Trials & End Points
  • IP/Patent Factors
  • Defensive Patent Strategies
  • Healthcare Economics

Company Profiles

Back to Top